MONTREAL--(BUSINESS WIRE)--Jan. 18, 2005--MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has appointed Robert D. Lefebvre vice president of Global Marketing. Mr. Lefebvre is responsible for all aspects of marketing strategy and implementation for the organization and is based at the King of Prussia, PA, office.

"With more than 20 years of international and interdisciplinary experience in marketing, sales and business development, Robert will assist in fortifying our marketing efforts and advancing our Pharma Services brand," noted Nigel Brown, senior vice president, Business Planning, Technologies and Markets for MDS Pharma Services.

Prior to joining MDS Pharma Services, Mr. Lefebvre was employed by Bristol-Myers Squibb Company, where he spent 12 years, most recently as vice-president and Brand Champion, Oncology Global Marketing. In addition, he has held marketing, product management and sales management positions at Sandoz Canada, Syntex Canada and Burroughs-Wellcome Canada. His advertising and marketing experience includes a tenure as account supervisor at one of Canada's largest healthcare advertising agencies.

About MDS Pharma Services and MDS Inc.

MDS Pharma Services offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, the company applies advanced scientific and technological expertise to each stage of the drug discovery and development process - Early Stage: lead optimization, pre-IND research, pharmaceutical and biopharmaceutical development, early clinical research (bioequivalence, phases I-IIa) and bioanalysis; and Late Stage: global clinical development (phases IIb-IV) and central lab. For more information, visit MDS Pharma Services' Web site at www.mdsps.com.

MDS Pharma Services is an integral part of MDS Inc. (TSX:MDS)(NYSE:MDZ). MDS Inc. has more than 9,000 highly skilled people in 25 countries providing a diverse range of superior products and services to increase our customers' speed, precision and productivity in the drug development and disease diagnosis processes. We are a global health and life sciences company, recognized for our reliability and collaborative relationships. Please refer to our website at www.mdsintl.com to find out more about how we help create better outcomes in the treatment of disease.

MDS Pharma Services (TSX:MDS) (NYSE:MDZ)